Insmed is not making widgets. They are a biotech development company. You know development where you must meet FDA and federal regulations.
This sector will always be volatile. The “quick fix” traders rule for now. Both longs and shorts.
The next positive news will quickly make up all of the losses plus! Don’t you all really down deep know this to be true?
The company has the same potential pipe line it had this past June!